Does 99Tcm-MIBI inhigh-grade malignant brain tumors reflect blood-brain barrierdamage only. Staudenherz A,Frazeny B,Marosi C,et al. Neuro Image(US) . 2008Staudenherz A,Fazeny B,Marosi C,et al. Does 99Tcm-MIBI in high-grade malignant brain tumors reflect blood-brain barrier damage only...
malignant gliomaradiotherapyDADAGAutoradiographic studies of labeled diacetyldianhydro-galactitol (DADAG) with tumor bearing animals revealed that the CNS accumulates high amounts of DADAG-derived radioactivity and the elimination from the brain seems to be relatively slow. This observation and the ...
Hypoxia has long been known to play a central role in gli- omagenesis and is related to a more malignant tumor phenotype and therapy resistance12. Accordingly, several studies have shown that HIF1αprotein expression increases with WHO grade13. In order to evaluate the large feature vectors...
Enrollment criteria included the following: age 18–75 years, which was modified to 12–75 years by protocol amendment; diagnosis of progressive/recurrent grade 3 or 4 malignant glioma18; IL-13Rα2+ tumor expression by immunohistochemistry (IHC); KPS ≥60; life expectancy >4 weeks; ...
High-grade gliomas (HGG; WHO grade 3 or 4) account for the majority of newly-diagnosed malignant brain tumors, with glioblastoma multiforme (GBM) representing the most common subtype [1]. These highly infiltrative and aggressive tumors generally have a poor prognosis, as they are difficult to ...
摘要: Malignant gliomas are the most common primary brain tumor in adults, with an incidence of five cases per 100,000 persons per year. Grade IV glioblastoma is the most aggressive form and prognosis remai关键词: Glioblastoma Malignant glioma Immunotherapy Tumor vaccine Bispecific antibody Checkpoint...
(1) An insulating electrode is placed on the skin of the tumor growth site for almost all cancers. The energy between the transducer arrays does not decay; thus, deep malignant tumors can also be treated, such as brain, lung, ovarian, and pancreatic cancers. (2) When combined with ...
Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas Although patients with newly diagnosed WHO grade 3 malignant glioma have a more favorable prognosis than those with WHO grade 4 malignant glioma, salvage t... A Desjardins,DA Reardon,JE Herndon,... - 《Clinical Cancer Research...
(2011) Induction of CD8 + T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with alpha-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma....
Target population Adults with imaging suggestive of a WHO grade II diffuse gliomas (oligodendrogliomas or astrocytomas) Question In adults with imaging sug